| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $59.6M | +1517.1% |
| Cost of Revenue | $5.0M | +561.4% |
| R&D Expense | $110.6M | -39.4% |
| SG&A Expense | $185.1M | +51.6% |
| Operating Income | -$241.1M | +20.1% |
| Interest Expense | $29.7M | +89.8% |
| Income Tax | $3.1M | — |
| Net Income | -$262.1M | +15.8% |
| EPS (Basic) | -$3.78 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $88.4M | +64.8% |
| Accounts Receivable | $25.8M | +205.1% |
| Inventory | $13.1M | +74.8% |
| Current Assets | $330.4M | -24.5% |
| Total Assets | $341.4M | -24.0% |
| Current Liabilities | $46.7M | +23.4% |
| Long-term Debt | $201.8M | +2.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$247.1M | +4.1% |
| Capital Expenditures | $428K | +28.5% |
| Investing Cash Flow | $180.2M | +306.7% |
| Financing Cash Flow | $101.3M | -66.4% |
| Free Cash Flow | -$247.5M | +4.1% |
| +33.2% |
| EPS (Diluted) | -$3.78 | +33.2% |
| Total Liabilities |
| $252.7M |
| +5.4% |
| Stockholders' Equity | $88.7M | -57.7% |